Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis

Overview

Journal Exp Hematol

Specialty Hematology

Date 2024 Oct 11

PMID 39393608

Authors

Hannah M Maul-Newby

Stephanie Halene

Affiliations

Soon will be listed here.

Abstract

Alternative splicing has long been recognized as a powerful tool to expand the diversity of the transcriptome and the proteome. The study of hematopoiesis, from hematopoietic stem cell maintenance and differentiation into committed progenitors to maturation into functional blood cells, has led the field of stem cell research and cellular differentiation for decades. The importance of aberrant splicing due to mutations in cis has been exemplified in thalassemias, resulting from aberrant expression of β-globin. The simultaneous development of increasingly sophisticated technologies, in particular the combination of multicolor flow cytometric cell sorting with bulk and single-cell sequencing, has provided sophisticated insights into the complex regulation of the blood system. The recognition that mutations in key splicing factors drive myeloid malignancies, in particular myelodysplastic syndromes, has galvanized research into alternative splicing in hematopoiesis and its diseases. In this review, we will update the audience on the exciting novel technologies, highlight alternative splicing events and their regulators with essential functions in hematopoiesis, and provide a high-level overview how splicing factor mutations contribute to hematologic malignancies.

References

Taylor J, Mi X, North K, Binder M, Penson A, Lasho T . Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms. Blood. 2020; 136(13):1477-1486. PMC: 7515689. DOI: 10.1182/blood.2020006868. View

Conboy J . RNA splicing during terminal erythropoiesis. Curr Opin Hematol. 2017; 24(3):215-221. PMC: 5636188. DOI: 10.1097/MOH.0000000000000329. View

Van Horebeek L, David M, Dedoncker N, Mallants K, Bijnens B, Goris A . A targeted sequencing extension for transcript genotyping in single-cell transcriptomics. Life Sci Alliance. 2023; 6(11). PMC: 10494938. DOI: 10.26508/lsa.202301971. View

Ullrich S, Guigo R . Dynamic changes in intron retention are tightly associated with regulation of splicing factors and proliferative activity during B-cell development. Nucleic Acids Res. 2019; 48(3):1327-1340. PMC: 7026658. DOI: 10.1093/nar/gkz1180. View

AlKhafaji A, Smith J, Garimella K, Babadi M, Popic V, Sade-Feldman M . High-throughput RNA isoform sequencing using programmed cDNA concatenation. Nat Biotechnol. 2023; 42(4):582-586. DOI: 10.1038/s41587-023-01815-7. View

Nam A, Kim K, Chaligne R, Izzo F, Ang C, Taylor J . Somatic mutations and cell identity linked by Genotyping of Transcriptomes. Nature. 2019; 571(7765):355-360. PMC: 6782071. DOI: 10.1038/s41586-019-1367-0. View

Graveley B, Maniatis T . Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing. Mol Cell. 1998; 1(5):765-71. DOI: 10.1016/s1097-2765(00)80076-3. View

Liang Y, Tebaldi T, Rejeski K, Joshi P, Stefani G, Taylor A . SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells. Leukemia. 2018; 32(12):2659-2671. PMC: 6274620. DOI: 10.1038/s41375-018-0152-7. View

Patnaik M, Lasho T, Finke C, Hanson C, Hodnefield J, Knudson R . Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance. Am J Hematol. 2013; 88(3):201-6. DOI: 10.1002/ajh.23373. View

10.

Hao T, Li-Talley M, Buck A, Chen W . An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States. Sci Rep. 2019; 9(1):12070. PMC: 6700310. DOI: 10.1038/s41598-019-48445-1. View

11.

Adams D, Altucci L, Antonarakis S, Ballesteros J, Beck S, Bird A . BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol. 2012; 30(3):224-6. DOI: 10.1038/nbt.2153. View

12.

Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D . Function of alternative splicing. Gene. 2005; 344:1-20. DOI: 10.1016/j.gene.2004.10.022. View

13.

Picelli S, Faridani O, Bjorklund A, Winberg G, Sagasser S, Sandberg R . Full-length RNA-seq from single cells using Smart-seq2. Nat Protoc. 2014; 9(1):171-81. DOI: 10.1038/nprot.2014.006. View

14.

Perriman R, Ares Jr M . Rearrangement of competing U2 RNA helices within the spliceosome promotes multiple steps in splicing. Genes Dev. 2007; 21(7):811-20. PMC: 1838532. DOI: 10.1101/gad.1524307. View

15.

Dumont N, Wang Y, Rudnicki M . Intrinsic and extrinsic mechanisms regulating satellite cell function. Development. 2015; 142(9):1572-81. PMC: 4419274. DOI: 10.1242/dev.114223. View

16.

Chen L, Chen J, Huang Y, Gu Y, Qiu J, Qian H . The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations. Mol Cell. 2018; 69(3):412-425.e6. PMC: 5957072. DOI: 10.1016/j.molcel.2017.12.029. View

17.

Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O . A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019; 10(1):2395. PMC: 6546699. DOI: 10.1038/s41467-019-10291-0. View

18.

Macosko E, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M . Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets. Cell. 2015; 161(5):1202-1214. PMC: 4481139. DOI: 10.1016/j.cell.2015.05.002. View

19.

Cazzola M, Rossi M, Malcovati L . Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood. 2012; 121(2):260-9. PMC: 3790951. DOI: 10.1182/blood-2012-09-399725. View

20.

Cilloni D, Itri F, Bonuomo V, Petiti J . Mutations in Hematological Malignancies. Cancers (Basel). 2022; 14(19). PMC: 9563056. DOI: 10.3390/cancers14194927. View